Aerovate Therapeutics
AVTE
#9168
Rank
C$0.10 B
Marketcap
$3.64
Share price
0.00%
Change (1 day)
-86.89%
Change (1 year)

Aerovate Therapeutics (AVTE) - Cash on Hand

Cash on Hand as of September 2024 : C$0.12 Billion

According to Aerovate Therapeutics's latest financial reports the company has C$0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Aerovate Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$0.17 B-17.8%
2021-12-31C$0.21 B3558.26%
2020-12-31C$5.83 M27.05%
2019-12-31C$4.58 M